Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
Open Access
- 20 January 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 37 (3) , 1387-1393
Abstract
Understanding the molecular processes characterizing Ewing sarcoma (EWS) cell migration is crucial to highlight novel therapies for patients with disseminated disease. In this study we analyzed the role of ROCK kinases in the regulation of cell migration, growth and differentiation of EWS cells. Overexpression of ROCK promotes invasion and metastasis in many solid tumors. However, the effect of ROCK in EWS has not been extensively investigated. Expression of ROCK1 and ROCK2 was analyzed by western blotting in a representative panel of human EWS cell lines, in comparison with the parameters of in vitro malignancy. We investigated the effects of a ROCK2 specific inhibitor toward those of a pan-ROCK inhibitor on the growth, migration and differentiation of two EWS cell lines. ROCK2 but not ROCK1 expression was found to be associated with in vitro cell migration and anchorage‑independent growth capabilities. Exposure of EWS cells to ROCK inhibitors significantly reduced migration and growth, while favoring morphology changes and neural differentiation. These effects were more striking when cells were specifically deprived of ROCK2 activity. Our findings lead to consider ROCK2, rather than ROCK1, as a possible molecular target for the treatment of EWS.Keywords
This publication has 33 references indexed in Scilit:
- Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiationAnnals of Oncology, 2012
- PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcomaJournal of Clinical Investigation, 2012
- Paxillin Mediates Sensing of Physical Cues and Regulates Directional Cell Motility by Controlling Lamellipodia PositioningPLOS ONE, 2011
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer CellsCell, 2011
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous systemActa Pharmacologica Sinica, 2010
- Growth Factors, Matrices, and Forces Combine and Control Stem CellsScience, 2009
- Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion #Hepatology, 2009
- Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -IIMolecular Biology of the Cell, 2007
- Response of Ewing tumor cells to forced and activated p53 expressionOncogene, 2003